nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—DRD2—nicotine dependence	0.681	1	CbGaD
Nortriptyline—Panic reaction—Varenicline—nicotine dependence	0.0157	0.101	CcSEcCtD
Nortriptyline—ORM1—saliva—nicotine dependence	0.00917	0.229	CbGeAlD
Nortriptyline—Withdrawal symptom—Varenicline—nicotine dependence	0.00769	0.0492	CcSEcCtD
Nortriptyline—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00643	0.0411	CcSEcCtD
Nortriptyline—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00608	0.0389	CcSEcCtD
Nortriptyline—Suicidal ideation—Varenicline—nicotine dependence	0.0045	0.0288	CcSEcCtD
Nortriptyline—Delusion—Varenicline—nicotine dependence	0.00445	0.0285	CcSEcCtD
Nortriptyline—Mania—Varenicline—nicotine dependence	0.00434	0.0277	CcSEcCtD
Nortriptyline—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00419	0.0268	CcSEcCtD
Nortriptyline—Gingivitis—Varenicline—nicotine dependence	0.00402	0.0257	CcSEcCtD
Nortriptyline—Mydriasis—Varenicline—nicotine dependence	0.00395	0.0253	CcSEcCtD
Nortriptyline—Nocturia—Varenicline—nicotine dependence	0.0034	0.0217	CcSEcCtD
Nortriptyline—Coordination abnormal—Varenicline—nicotine dependence	0.00321	0.0205	CcSEcCtD
Nortriptyline—Nightmare—Varenicline—nicotine dependence	0.00304	0.0195	CcSEcCtD
Nortriptyline—Disorientation—Varenicline—nicotine dependence	0.00256	0.0164	CcSEcCtD
Nortriptyline—Eye pain—Varenicline—nicotine dependence	0.00254	0.0162	CcSEcCtD
Nortriptyline—Libido decreased—Varenicline—nicotine dependence	0.00247	0.0158	CcSEcCtD
Nortriptyline—Hot flush—Varenicline—nicotine dependence	0.00245	0.0157	CcSEcCtD
Nortriptyline—Menopausal symptoms—Varenicline—nicotine dependence	0.00243	0.0155	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Varenicline—nicotine dependence	0.00234	0.0149	CcSEcCtD
Nortriptyline—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00227	0.0145	CcSEcCtD
Nortriptyline—Psychotic disorder—Varenicline—nicotine dependence	0.00224	0.0143	CcSEcCtD
Nortriptyline—Irritability—Varenicline—nicotine dependence	0.00218	0.014	CcSEcCtD
Nortriptyline—Urinary retention—Varenicline—nicotine dependence	0.00218	0.0139	CcSEcCtD
Nortriptyline—Pollakiuria—Varenicline—nicotine dependence	0.00183	0.0117	CcSEcCtD
Nortriptyline—Erectile dysfunction—Varenicline—nicotine dependence	0.00182	0.0117	CcSEcCtD
Nortriptyline—Weight increased—Varenicline—nicotine dependence	0.0018	0.0115	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Varenicline—nicotine dependence	0.00174	0.0111	CcSEcCtD
Nortriptyline—Myocardial infarction—Varenicline—nicotine dependence	0.00173	0.0111	CcSEcCtD
Nortriptyline—CHRM2—cardiovascular system—nicotine dependence	0.00172	0.043	CbGeAlD
Nortriptyline—Stomatitis—Varenicline—nicotine dependence	0.00172	0.011	CcSEcCtD
Nortriptyline—CHRM4—brain—nicotine dependence	0.00158	0.0393	CbGeAlD
Nortriptyline—Hypoaesthesia—Varenicline—nicotine dependence	0.00158	0.0101	CcSEcCtD
Nortriptyline—Hallucination—Varenicline—nicotine dependence	0.00158	0.0101	CcSEcCtD
Nortriptyline—CHRM1—cardiovascular system—nicotine dependence	0.00157	0.0391	CbGeAlD
Nortriptyline—Oedema peripheral—Varenicline—nicotine dependence	0.00156	0.00998	CcSEcCtD
Nortriptyline—Eye disorder—Varenicline—nicotine dependence	0.00148	0.00947	CcSEcCtD
Nortriptyline—Tinnitus—Varenicline—nicotine dependence	0.00148	0.00945	CcSEcCtD
Nortriptyline—Arrhythmia—Varenicline—nicotine dependence	0.00141	0.00905	CcSEcCtD
Nortriptyline—HTR6—brain—nicotine dependence	0.00141	0.0352	CbGeAlD
Nortriptyline—HTR1A—cardiovascular system—nicotine dependence	0.0014	0.0349	CbGeAlD
Nortriptyline—Dysgeusia—Varenicline—nicotine dependence	0.00135	0.00864	CcSEcCtD
Nortriptyline—Vision blurred—Varenicline—nicotine dependence	0.0013	0.00831	CcSEcCtD
Nortriptyline—HTR2C—midbrain—nicotine dependence	0.0013	0.0324	CbGeAlD
Nortriptyline—Tremor—Varenicline—nicotine dependence	0.00129	0.00826	CcSEcCtD
Nortriptyline—ADRA1A—cardiovascular system—nicotine dependence	0.00129	0.0322	CbGeAlD
Nortriptyline—Ill-defined disorder—Varenicline—nicotine dependence	0.00128	0.00818	CcSEcCtD
Nortriptyline—Agitation—Varenicline—nicotine dependence	0.00127	0.00811	CcSEcCtD
Nortriptyline—Malaise—Varenicline—nicotine dependence	0.00124	0.00795	CcSEcCtD
Nortriptyline—Syncope—Varenicline—nicotine dependence	0.00124	0.00791	CcSEcCtD
Nortriptyline—CHRM5—brain—nicotine dependence	0.00123	0.0307	CbGeAlD
Nortriptyline—SLC6A4—midbrain—nicotine dependence	0.00123	0.0307	CbGeAlD
Nortriptyline—Palpitations—Varenicline—nicotine dependence	0.00122	0.00779	CcSEcCtD
Nortriptyline—Loss of consciousness—Varenicline—nicotine dependence	0.00121	0.00775	CcSEcCtD
Nortriptyline—Convulsion—Varenicline—nicotine dependence	0.00119	0.00764	CcSEcCtD
Nortriptyline—Hypertension—Varenicline—nicotine dependence	0.00119	0.00761	CcSEcCtD
Nortriptyline—Anxiety—Varenicline—nicotine dependence	0.00117	0.00748	CcSEcCtD
Nortriptyline—Discomfort—Varenicline—nicotine dependence	0.00116	0.00742	CcSEcCtD
Nortriptyline—Dry mouth—Varenicline—nicotine dependence	0.00115	0.00734	CcSEcCtD
Nortriptyline—ADRA1B—brain—nicotine dependence	0.00113	0.0281	CbGeAlD
Nortriptyline—Oedema—Varenicline—nicotine dependence	0.00112	0.0072	CcSEcCtD
Nortriptyline—Shock—Varenicline—nicotine dependence	0.00111	0.00708	CcSEcCtD
Nortriptyline—ADRA1D—brain—nicotine dependence	0.0011	0.0275	CbGeAlD
Nortriptyline—Thrombocytopenia—Varenicline—nicotine dependence	0.0011	0.00705	CcSEcCtD
Nortriptyline—Tachycardia—Varenicline—nicotine dependence	0.0011	0.00703	CcSEcCtD
Nortriptyline—HTR1A—midbrain—nicotine dependence	0.00109	0.0272	CbGeAlD
Nortriptyline—Hyperhidrosis—Varenicline—nicotine dependence	0.00109	0.00696	CcSEcCtD
Nortriptyline—Anorexia—Varenicline—nicotine dependence	0.00107	0.00686	CcSEcCtD
Nortriptyline—Hypotension—Varenicline—nicotine dependence	0.00105	0.00673	CcSEcCtD
Nortriptyline—Insomnia—Varenicline—nicotine dependence	0.00102	0.00651	CcSEcCtD
Nortriptyline—CYP2C9—cardiovascular system—nicotine dependence	0.00101	0.0252	CbGeAlD
Nortriptyline—Somnolence—Varenicline—nicotine dependence	0.001	0.0064	CcSEcCtD
Nortriptyline—Dyspepsia—Varenicline—nicotine dependence	0.00099	0.00634	CcSEcCtD
Nortriptyline—DRD2—midbrain—nicotine dependence	0.000987	0.0246	CbGeAlD
Nortriptyline—Decreased appetite—Varenicline—nicotine dependence	0.000978	0.00626	CcSEcCtD
Nortriptyline—Fatigue—Varenicline—nicotine dependence	0.00097	0.00621	CcSEcCtD
Nortriptyline—Constipation—Varenicline—nicotine dependence	0.000962	0.00616	CcSEcCtD
Nortriptyline—CYP2E1—cardiovascular system—nicotine dependence	0.000959	0.0239	CbGeAlD
Nortriptyline—Feeling abnormal—Varenicline—nicotine dependence	0.000927	0.00593	CcSEcCtD
Nortriptyline—PTGS1—cardiovascular system—nicotine dependence	0.000924	0.023	CbGeAlD
Nortriptyline—Urticaria—Varenicline—nicotine dependence	0.000894	0.00572	CcSEcCtD
Nortriptyline—Abdominal pain—Varenicline—nicotine dependence	0.000889	0.00569	CcSEcCtD
Nortriptyline—Body temperature increased—Varenicline—nicotine dependence	0.000889	0.00569	CcSEcCtD
Nortriptyline—Maprotiline—DRD2—nicotine dependence	0.000852	0.157	CrCbGaD
Nortriptyline—CHRM2—brain—nicotine dependence	0.000846	0.0211	CbGeAlD
Nortriptyline—HTR2A—cardiovascular system—nicotine dependence	0.000834	0.0208	CbGeAlD
Nortriptyline—Hypersensitivity—Varenicline—nicotine dependence	0.000829	0.0053	CcSEcCtD
Nortriptyline—HTR2C—brain—nicotine dependence	0.000816	0.0203	CbGeAlD
Nortriptyline—Asthenia—Varenicline—nicotine dependence	0.000807	0.00516	CcSEcCtD
Nortriptyline—Pruritus—Varenicline—nicotine dependence	0.000796	0.00509	CcSEcCtD
Nortriptyline—ALB—brain—nicotine dependence	0.000796	0.0198	CbGeAlD
Nortriptyline—SLC6A4—brain—nicotine dependence	0.000773	0.0193	CbGeAlD
Nortriptyline—CHRM1—brain—nicotine dependence	0.00077	0.0192	CbGeAlD
Nortriptyline—Diarrhoea—Varenicline—nicotine dependence	0.00077	0.00493	CcSEcCtD
Nortriptyline—Cyproheptadine—DRD2—nicotine dependence	0.000756	0.139	CrCbGaD
Nortriptyline—Dizziness—Varenicline—nicotine dependence	0.000744	0.00476	CcSEcCtD
Nortriptyline—Vomiting—Varenicline—nicotine dependence	0.000715	0.00458	CcSEcCtD
Nortriptyline—Rash—Varenicline—nicotine dependence	0.000709	0.00454	CcSEcCtD
Nortriptyline—Dermatitis—Varenicline—nicotine dependence	0.000709	0.00453	CcSEcCtD
Nortriptyline—Headache—Varenicline—nicotine dependence	0.000705	0.00451	CcSEcCtD
Nortriptyline—CHRM3—brain—nicotine dependence	0.000689	0.0172	CbGeAlD
Nortriptyline—HTR1A—brain—nicotine dependence	0.000687	0.0171	CbGeAlD
Nortriptyline—SLC6A2—brain—nicotine dependence	0.000681	0.017	CbGeAlD
Nortriptyline—Nausea—Varenicline—nicotine dependence	0.000668	0.00428	CcSEcCtD
Nortriptyline—HTR2A—midbrain—nicotine dependence	0.000651	0.0162	CbGeAlD
Nortriptyline—Amitriptyline—OPRM1—nicotine dependence	0.000648	0.119	CrCbGaD
Nortriptyline—ADRA1A—brain—nicotine dependence	0.000633	0.0158	CbGeAlD
Nortriptyline—DRD2—brain—nicotine dependence	0.00062	0.0155	CbGeAlD
Nortriptyline—Mianserin—DRD2—nicotine dependence	0.000573	0.106	CrCbGaD
Nortriptyline—Chlorprothixene—DRD2—nicotine dependence	0.000522	0.0961	CrCbGaD
Nortriptyline—HRH1—brain—nicotine dependence	0.00049	0.0122	CbGeAlD
Nortriptyline—Trimipramine—DRD2—nicotine dependence	0.000482	0.0888	CrCbGaD
Nortriptyline—CYP2E1—brain—nicotine dependence	0.000471	0.0117	CbGeAlD
Nortriptyline—Doxepin—DRD2—nicotine dependence	0.000459	0.0847	CrCbGaD
Nortriptyline—PTGS1—brain—nicotine dependence	0.000454	0.0113	CbGeAlD
Nortriptyline—Desipramine—DRD2—nicotine dependence	0.000421	0.0777	CrCbGaD
Nortriptyline—HTR2A—brain—nicotine dependence	0.000409	0.0102	CbGeAlD
Nortriptyline—CYP2D6—brain—nicotine dependence	0.000373	0.00929	CbGeAlD
Nortriptyline—Imipramine—DRD2—nicotine dependence	0.000357	0.0659	CrCbGaD
Nortriptyline—Amitriptyline—DRD2—nicotine dependence	0.000355	0.0655	CrCbGaD
Nortriptyline—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000155	0.00132	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000155	0.00132	CbGpPWpGaD
Nortriptyline—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000155	0.00132	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000154	0.00132	CbGpPWpGaD
Nortriptyline—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000154	0.00132	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000154	0.00131	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000154	0.00131	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000152	0.0013	CbGpPWpGaD
Nortriptyline—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000152	0.0013	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000152	0.0013	CbGpPWpGaD
Nortriptyline—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000152	0.00129	CbGpPWpGaD
Nortriptyline—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000151	0.00129	CbGpPWpGaD
Nortriptyline—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000151	0.00129	CbGpPWpGaD
Nortriptyline—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000149	0.00127	CbGpPWpGaD
Nortriptyline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000149	0.00127	CbGpPWpGaD
Nortriptyline—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000149	0.00127	CbGpPWpGaD
Nortriptyline—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000148	0.00126	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.000147	0.00125	CbGpPWpGaD
Nortriptyline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000146	0.00125	CbGpPWpGaD
Nortriptyline—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000145	0.00124	CbGpPWpGaD
Nortriptyline—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000143	0.00122	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000143	0.00122	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000141	0.00121	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000141	0.0012	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000141	0.0012	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000141	0.0012	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00014	0.0012	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00014	0.0012	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00014	0.00119	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000138	0.00118	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000138	0.00118	CbGpPWpGaD
Nortriptyline—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000136	0.00116	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000134	0.00115	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000134	0.00114	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000133	0.00114	CbGpPWpGaD
Nortriptyline—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000131	0.00112	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.00013	0.00111	CbGpPWpGaD
Nortriptyline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000128	0.00109	CbGpPWpGaD
Nortriptyline—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000128	0.00109	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000128	0.00109	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000128	0.00109	CbGpPWpGaD
Nortriptyline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000128	0.00109	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000127	0.00109	CbGpPWpGaD
Nortriptyline—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000127	0.00109	CbGpPWpGaD
Nortriptyline—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000127	0.00109	CbGpPWpGaD
Nortriptyline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000127	0.00108	CbGpPWpGaD
Nortriptyline—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000126	0.00107	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000126	0.00107	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000124	0.00106	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR ligand binding—DRD2—nicotine dependence	0.000124	0.00105	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TAS2R16—nicotine dependence	0.000123	0.00105	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000122	0.00104	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000122	0.00104	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000122	0.00104	CbGpPWpGaD
Nortriptyline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000121	0.00103	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000121	0.00103	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000121	0.00103	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00012	0.00102	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000119	0.00102	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR ligand binding—DRD2—nicotine dependence	0.000118	0.00101	CbGpPWpGaD
Nortriptyline—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000118	0.001	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TAS2R16—nicotine dependence	0.000118	0.001	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000116	0.000988	CbGpPWpGaD
Nortriptyline—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000116	0.000986	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000115	0.000982	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000115	0.000979	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000114	0.00097	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000113	0.000967	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000112	0.000959	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000111	0.000948	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000111	0.000944	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000111	0.000943	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.00011	0.000941	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.00011	0.000938	CbGpPWpGaD
Nortriptyline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00011	0.000938	CbGpPWpGaD
Nortriptyline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00011	0.000936	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.00011	0.000935	CbGpPWpGaD
Nortriptyline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000109	0.000933	CbGpPWpGaD
Nortriptyline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000109	0.00093	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000109	0.000926	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000108	0.000924	CbGpPWpGaD
Nortriptyline—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000108	0.000921	CbGpPWpGaD
Nortriptyline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000108	0.000918	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	0.000102	0.000873	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—FGD1—nicotine dependence	0.000102	0.000872	CbGpPWpGaD
Nortriptyline—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	9.84e-05	0.000839	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	9.69e-05	0.000827	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—OPRM1—nicotine dependence	9.66e-05	0.000823	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	9.64e-05	0.000822	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	9.64e-05	0.000822	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—FGD1—nicotine dependence	9.64e-05	0.000822	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	9.59e-05	0.000818	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	9.3e-05	0.000793	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	9.25e-05	0.000788	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—FGD1—nicotine dependence	9.23e-05	0.000787	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	9.23e-05	0.000787	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	9.18e-05	0.000783	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	9.03e-05	0.00077	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	8.77e-05	0.000748	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	8.69e-05	0.000741	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	8.68e-05	0.00074	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	8.52e-05	0.000726	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	8.47e-05	0.000722	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	8.4e-05	0.000716	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	8.37e-05	0.000714	CbGpPWpGaD
Nortriptyline—HRH1—GPCR ligand binding—DRD2—nicotine dependence	8.36e-05	0.000713	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	8.33e-05	0.00071	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	8.33e-05	0.00071	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	8.31e-05	0.000709	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	8.3e-05	0.000708	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	8.29e-05	0.000706	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	8.26e-05	0.000704	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	8.22e-05	0.000701	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	8.2e-05	0.000699	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	8.18e-05	0.000697	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	8.16e-05	0.000695	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	8.16e-05	0.000695	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	7.9e-05	0.000673	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	7.67e-05	0.000654	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	7.58e-05	0.000646	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—FGD1—nicotine dependence	7.57e-05	0.000645	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	7.54e-05	0.000643	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—FGD1—nicotine dependence	7.53e-05	0.000642	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	7.4e-05	0.000631	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	7.22e-05	0.000615	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	7.21e-05	0.000614	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—CYP2A7—nicotine dependence	7.18e-05	0.000612	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	6.98e-05	0.000595	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.88e-05	0.000587	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6.85e-05	0.000584	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—DRD2—nicotine dependence	6.72e-05	0.000573	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	6.69e-05	0.00057	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	6.68e-05	0.00057	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	6.65e-05	0.000567	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	6.65e-05	0.000567	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—FGD1—nicotine dependence	6.64e-05	0.000566	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	6.55e-05	0.000559	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	6.55e-05	0.000558	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—FGD1—nicotine dependence	6.54e-05	0.000557	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	6.53e-05	0.000557	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—FGD1—nicotine dependence	6.52e-05	0.000556	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	6.51e-05	0.000555	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—FGD1—nicotine dependence	6.5e-05	0.000554	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	6.49e-05	0.000553	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—FGD1—nicotine dependence	6.48e-05	0.000553	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	6.43e-05	0.000548	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—FGD1—nicotine dependence	6.42e-05	0.000547	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	6.41e-05	0.000547	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	6.4e-05	0.000546	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	6.36e-05	0.000543	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CYP2A7—nicotine dependence	6.36e-05	0.000543	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—WASF2—nicotine dependence	6.36e-05	0.000542	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	6.34e-05	0.000541	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	6.29e-05	0.000536	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—WASF1—nicotine dependence	6.1e-05	0.00052	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	6.07e-05	0.000518	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	6.04e-05	0.000515	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—WASF2—nicotine dependence	6e-05	0.000512	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.94e-05	0.000507	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	5.93e-05	0.000506	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	5.91e-05	0.000504	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	5.89e-05	0.000503	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.87e-05	0.0005	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	5.84e-05	0.000498	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	5.82e-05	0.000496	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.77e-05	0.000492	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	5.76e-05	0.000491	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—WASF1—nicotine dependence	5.75e-05	0.000491	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—WASF2—nicotine dependence	5.75e-05	0.00049	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	5.74e-05	0.00049	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	5.72e-05	0.000488	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	5.71e-05	0.000487	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	5.67e-05	0.000483	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	5.65e-05	0.000482	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—WASF1—nicotine dependence	5.51e-05	0.00047	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—OPRM1—nicotine dependence	5.49e-05	0.000468	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	5.48e-05	0.000467	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	5.45e-05	0.000465	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	5.4e-05	0.000461	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CYP2A7—nicotine dependence	5.36e-05	0.000457	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CYP2A7—nicotine dependence	5.35e-05	0.000456	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	5.22e-05	0.000445	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	5.18e-05	0.000442	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	5.18e-05	0.000442	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.97e-05	0.000424	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	4.96e-05	0.000423	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.95e-05	0.000422	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	4.74e-05	0.000404	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.73e-05	0.000404	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	4.72e-05	0.000403	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.71e-05	0.000402	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	4.71e-05	0.000401	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	4.69e-05	0.0004	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.68e-05	0.000399	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	4.66e-05	0.000398	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	4.65e-05	0.000396	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	4.63e-05	0.000395	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYP2A7—nicotine dependence	4.61e-05	0.000393	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—WASF1—nicotine dependence	4.51e-05	0.000385	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—WASF1—nicotine dependence	4.49e-05	0.000383	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	4.48e-05	0.000382	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	4.3e-05	0.000367	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	4.3e-05	0.000366	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—DRD2—nicotine dependence	4.29e-05	0.000366	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	4.27e-05	0.000364	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	4.26e-05	0.000363	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	4.22e-05	0.00036	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	4.21e-05	0.000359	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP2A7—nicotine dependence	4.14e-05	0.000353	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—WASF2—nicotine dependence	4.13e-05	0.000353	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—WASF2—nicotine dependence	4.07e-05	0.000347	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	4.06e-05	0.000347	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—WASF2—nicotine dependence	4.06e-05	0.000346	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—WASF2—nicotine dependence	4.05e-05	0.000345	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	4.04e-05	0.000345	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—WASF2—nicotine dependence	4.03e-05	0.000344	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—WASF2—nicotine dependence	3.99e-05	0.000341	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.98e-05	0.00034	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD2—nicotine dependence	3.97e-05	0.000339	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.96e-05	0.000338	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.9e-05	0.000333	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—WASF1—nicotine dependence	3.89e-05	0.000332	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—WASF1—nicotine dependence	3.88e-05	0.000331	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	3.87e-05	0.00033	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—WASF1—nicotine dependence	3.87e-05	0.00033	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—WASF1—nicotine dependence	3.83e-05	0.000327	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.82e-05	0.000326	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.81e-05	0.000325	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP2A7—nicotine dependence	3.77e-05	0.000322	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD2—nicotine dependence	3.75e-05	0.000319	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD2—nicotine dependence	3.59e-05	0.000306	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.57e-05	0.000304	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.51e-05	0.000299	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—OPRM1—nicotine dependence	3.5e-05	0.000299	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	3.49e-05	0.000298	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	3.48e-05	0.000297	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	3.45e-05	0.000294	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.44e-05	0.000293	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	3.37e-05	0.000288	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP2A7—nicotine dependence	3.22e-05	0.000275	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.94e-05	0.000251	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.92e-05	0.000249	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	2.8e-05	0.000239	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.54e-05	0.000216	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.53e-05	0.000216	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD2—nicotine dependence	2.53e-05	0.000215	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD2—nicotine dependence	2.52e-05	0.000215	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD2—nicotine dependence	2.49e-05	0.000213	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.49e-05	0.000212	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.49e-05	0.000212	CbGpPWpGaD
